Drug Type Synthetic peptide |
Synonyms C2816 |
Target |
Mechanism CCKA agonists(Cholecystokinin A receptor agonists), GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | US | 19 May 2018 | |
Diabetes Mellitus | Preclinical | GB | 19 May 2018 | |
Obesity | Preclinical | US | 19 May 2018 | |
Obesity | Preclinical | GB | 19 May 2018 |